Sofic Amela, Cizmic Midhat, Beslagic Eldina, Becirevic Muhidin, Mujakovic Aida, Husic-Selimovic Azra, Granov Lejla Aladjuz
General Hospital "Prim. dr. Abdulah Nakas", Sarajevo, Sarajevo, Bosnia and Herzegovina.
Mater Sociomed. 2022 Jun;34(2):95-99. doi: 10.5455/msm.2022.34.95-99.
The Brixia scoring system interpreted chest X-ray changes, serves as an indicator of the extent of changes in the lung parenchyma.
To indicate the effect of D-dimer and C-reactive protein (CRP) on Brixia score in patients with positive polymerase chain reaction (PCR) test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The research had prospective, descriptive and analytical character, and included patients (n=104) with Coronavirus disease 2019 (COVID-19) diagnosis. Chest X-ray, as well as calculation of Brixia score was done on admission, in the first week of hospitalization, on discharge, and 10 days after discharge (the patient was considered a post-COVID patient. Maximum CRP and D-dimer values were taken into account, along with data about dependence of mechanical ventilation and oxygen therapy.
Initial Brixia score was significantly associated with the values of CRP (r = .23, p <.05). Higher level of CRP affected the higher result on the Brixia score after the initial X-ray. High CRP and D-dimer were significantly associated with oxygen use in patients, while high D-dimer was also statistically significantly associated with comorbidity. The mean value of Brixia score (during four time points) was significantly related to the values of CRP, D-dimer, the use of mechanical ventilation and oxygen therapy, but also with the existence of comorbidities. The largest statistically significant positive correlation of Brixia scora is with the values of D-dimer (r = .45, p <.000), but also with the values of CRP (r = .36, p <.000).
Values of CRP have an impact on Brixia score. Investigation of clinical characteristics and outcomes of severe clinical presentation of COVID-19 along with CXR scoring system will contribute to early prediction, accurate diagnosis and treatment as well as to improve the prognosis of patients with severe illness.
布里夏评分系统用于解读胸部X线变化,可作为肺实质变化程度的指标。
探讨D-二聚体和C反应蛋白(CRP)对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)聚合酶链反应(PCR)检测呈阳性的患者布里夏评分的影响。
本研究具有前瞻性、描述性和分析性,纳入了104例2019冠状病毒病(COVID-19)确诊患者。入院时、住院第一周、出院时以及出院后10天(此时患者被视为COVID后患者)进行胸部X线检查并计算布里夏评分。记录最高CRP和D-二聚体值,以及机械通气和氧疗的依赖数据。
初始布里夏评分与CRP值显著相关(r = 0.23,p < 0.05)。较高水平的CRP会使初始X线检查后的布里夏评分结果更高。高CRP和D-二聚体与患者吸氧显著相关,而高D-二聚体与合并症也具有统计学显著相关性。布里夏评分的平均值(在四个时间点)与CRP、D-二聚体值、机械通气和氧疗的使用显著相关,也与合并症的存在相关。布里夏评分与D-二聚体值的统计学显著正相关性最大(r = 0.45,p < 0.000),与CRP值的相关性也最大(r = 0.36,p < 0.000)。
CRP值对布里夏评分有影响。对COVID-19严重临床表现的临床特征和结局进行调查,并结合胸部X线评分系统,将有助于早期预测、准确诊断和治疗,以及改善重症患者的预后。